台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    117.0
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    63
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
智基 (6294)籌碼相關-國票-九鼎 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

國票-九鼎 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/1800.000.4117.00117.00-0.4112-0.31%
2024/04/161115.5000.00114.0011110.90%
2024/04/1200.001.1118.05118.00-1.1104-1.05%
2024/04/111118.0000.00119.5011010.98%
2024/04/1000.002127.50127.00-295-2.09%
2024/04/023123.1700.00123.503704.24%
2024/03/270.1123.5000.00122.000.1660.15%
2024/03/201121.5000.00121.501561.77%
2024/03/141119.5000.00119.001432.31%
2024/02/0200.002112.00112.00-231-6.31%
2024/01/112111.5000.00111.502296.85%
2024/01/0900.0014111.96112.50-1427-50.33%
2023/12/2000.004114.00114.50-423-16.97%
2023/12/014113.0000.00113.0042118.79%
2023/11/131112.5000.00112.501214.74%
2023/11/011114.0000.00114.001205.00%
2023/10/301115.0000.00115.001205.00%
2023/10/251115.5000.00116.501224.54%
2023/10/242116.0000.00116.002228.99%
2023/10/232116.0000.00117.002228.84%
2023/10/203116.3300.00117.0032312.90%
2023/10/161116.5000.00116.501244.06%
2023/10/1300.001116.50117.00-125-3.99%
2023/10/111116.5000.00116.501253.95%
2023/10/031115.0000.00116.001263.84%
2023/09/211114.0000.00114.001263.74%
2023/09/121113.5000.00113.501273.70%
2023/08/301111.5000.00111.501303.31%
2023/05/1700.001109.00108.00-155-1.79%
2023/04/121119.0000.00119.001422.35%
2023/01/1700.001109.00108.50-139-2.55%
2022/12/2800.001107.00107.50-139-2.53%
2022/12/091103.5000.00103.501382.57%
2022/12/0800.001105.00105.00-138-2.60%
2022/11/291100.0000.00100.001273.69%
2022/11/0100.00199.6099.00-118-5.43%
2022/10/31199.2000.0099.201175.66%
2022/07/2000.001112.00112.00-143-2.28%
2022/06/22198.0000.0098.001462.17%
2022/04/1400.001125.50126.00-125-3.95%
2022/04/1100.005133.50134.50-522-21.87%
2022/03/2100.000.5131.50132.00-0.519-2.60%
2022/03/185127.802127.50128.0031816.20%
2022/03/1700.001125.50126.50-118-5.47%
2022/03/1600.001125.06125.50-118-5.21%
2022/03/1500.001124.52125.00-121-4.79%
2022/02/232126.0000.00125.502219.28%
2021/11/1700.001127.00128.00-130-3.28%
2021/11/121127.5000.00127.001293.36%
2021/10/121133.5000.00132.501372.69%
2021/09/1700.000.1144.00144.50-0.133-0.24%
2021/09/1600.000144.00143.50033-0.05%
2021/09/080.4143.930.2143.50141.000.2340.58%
2021/08/200.1147.0000.00146.000.1360.28%
2021/07/091151.0000.00150.501333.00%
2021/07/0700.001152.50152.50-135-2.83%
2021/07/0200.001152.00152.00-139-2.51%
2021/06/171154.0000.00154.001462.14%
2021/05/031146.0000.00146.001382.62%
2021/04/0800.001142.50142.00-132-3.10%
2021/04/011139.5000.00139.501303.25%
2021/03/311143.5000.00143.001293.40%
2021/03/2200.002140.50140.50-225-7.75%
2021/03/1900.001135.50136.00-125-3.94%
2021/02/011121.501121.50121.500350.00%
2020/12/210122.5000.00124.500360.08%
2020/12/180.3121.0000.00122.500.3360.75%
2020/12/100.3123.0000.00125.500.3330.89%
2020/12/0300.001125.00127.00-132-3.09%
2020/11/180.2120.0000.00120.500.2340.44%
2020/11/110.2116.5000.00118.000.2330.45%
2020/10/0500.001114.50114.50-135-2.81%
2020/09/181110.5000.00110.501402.46%
2020/09/0800.002110.00111.50-254-3.68%
2020/08/311114.001114.00114.000580.00%
2020/08/282112.251115.00113.001581.71%
2020/08/191107.5000.00108.501571.74%
2020/07/2200.001106.50107.50-163-1.57%
2020/07/021107.0000.00107.501621.61%
2020/06/2900.001107.00107.50-162-1.61%
2020/06/161113.5000.00112.501521.89%
2020/04/155101.0000.00101.0054211.70%
2020/04/14199.7000.00101.001422.35%
2020/04/13499.4800.0099.204429.38%
2020/03/10299.6500.00100.002287.08%
2020/02/261101.0000.00101.001263.83%
2019/11/1200.001102.50102.50-121-4.74%
2019/05/031109.5000.00109.001402.45%
2019/04/2300.001109.50109.50-140-2.50%
2019/04/191108.0000.00107.501382.57%
2019/03/221111.5000.00111.001303.23%
2018/11/091104.5000.00104.501293.41%
2018/09/031109.0000.00109.501531.88%
2018/05/101128.0000.00128.5011270.79%
2018/05/041131.001128.00128.5001170.00%
2018/03/311130.0000.00129.5011600.62%
2018/01/2400.001123.00124.00-1158-0.63%
2018/01/221123.0000.00122.5011520.66%
2018/01/191127.502126.25124.00-1148-0.67%
2018/01/171121.0000.00121.5011290.77%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音